[1]
R. Chen, X. Gao, and Y. Shen, “MiR-3195 inhibits non-small cell lung cancer malignant behaviors along with cisplatin resistance through targeting PFKFB4: MiR-3195 inhibits NSCLC through PFKFB4”, Cell Mol Biol (Noisy-le-grand), vol. 70, no. 7, pp. 73–78, Jul. 2024.